Machine Learning-Assisted Ensemble Analysis for the Prediction of Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer

被引:2
作者
Huang, Yibao [1 ]
Zhu, Qingqing [1 ]
Xue, Liru [1 ]
Zhu, Xiaoran [1 ]
Chen, Yingying [1 ]
Wu, Mingfu [1 ]
机构
[1] Huazhong Univ Sci & Technol, Natl Clin Res Ctr Obstetr & Gynecol Dis, Key Lab Canc Invas & Metastasis, Tongji Hosp,Tongji Med Coll,Dept Gynecol,Minist E, Wuhan, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
locally advanced cervical cancer; neoadjuvant chemotherapy; machine learning analysis; predictive model; pathology response; INFLAMMATION MARKERS; RADICAL HYSTERECTOMY; CURATIVE RESECTION; SURGERY; VALIDATION; FIBRINOGEN; EFFICACY;
D O I
10.3389/fonc.2022.817250
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The clinical benefit of neoadjuvant chemotherapy (NACT) before concurrent chemoradiotherapy (CCRT) vs. adjuvant chemotherapy after CCRT is debated. Non-response to platinum-based NACT is a major contributor to poor prognosis, but there is currently no reliable method for predicting the response to NACT (rNACT) in patients with locally advanced cervical cancer (LACC). In this study we developed a machine learning (ML)-assisted model to accurately predict rNACT. We retrospectively analyzed data on 636 patients diagnosed with stage IB2 to IIA2 cervical cancer at our hospital between January 1, 2010 and December 1, 2020. Five ML-assisted models were developed from candidate clinical features using 2-step estimation methods. Receiver operating characteristic curve (ROC), clinical impact curve, and decision curve analyses were performed to evaluate the robustness and clinical applicability of each model. A total of 30 candidate variables were ultimately included in the rNACT prediction model. The areas under the ROC curve of models constructed using the random forest classifier (RFC), support vector machine, eXtreme gradient boosting, artificial neural network, and decision tree ranged from 0.682 to 0.847. The RFC model had the highest predictive accuracy, which was achieved by incorporating inflammatory factors such as platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio, neutrophil-to-albumin ratio, and lymphocyte-to-monocyte ratio. These results demonstrate that the ML-based prediction model developed using the RFC can be used to identify LACC patients who are likely to respond to rNACT, which can guide treatment selection and improve clinical outcomes.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Neoadjuvant chemotherapy followed by robotic radical hysterectomy in locally advanced cervical cancer: A multi-institution study
    Vizza, Enrico
    Corrado, Giacomo
    Zanagnolo, Vanna
    Tomaselli, Tiziana
    Cutillo, Giuseppe
    Mancini, Emanuela
    Maggioni, Angelo
    GYNECOLOGIC ONCOLOGY, 2014, 133 (02) : 180 - 185
  • [42] Circulating miR-326 could serve as a predictive biomarker for response to neoadjuvant chemotherapy in locally advanced cervical cancer
    Zou, Kangni
    Yang, E.
    Cui, Tao
    Li, Zhengyu
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [43] Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer
    Sirohi, Bhawna
    Mitra, Abhishek
    Jagannath, Palepu
    Singh, Ashish
    Ramadvar, Mukta
    Kulkarni, Suyash
    Goel, Mahesh
    Shrikhande, Shailesh V.
    FUTURE ONCOLOGY, 2015, 11 (10) : 1501 - 1509
  • [44] Deep learning nomogram for predicting neoadjuvant chemotherapy response in locally advanced gastric cancer patients
    Zhang, Jingjing
    Zhang, Qiang
    Zhao, Bo
    Shi, Gaofeng
    ABDOMINAL RADIOLOGY, 2024, 49 (11) : 3780 - 3796
  • [45] A Machine Learning Model for Predicting a Major Response to Neoadjuvant Chemotherapy in Advanced Gastric Cancer
    Chen, Yonghe
    Wei, Kaikai
    Liu, Dan
    Xiang, Jun
    Wang, Gang
    Meng, Xiaochun
    Peng, Junsheng
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [46] Retrospective comparison of laparoscopic versus open radical hysterectomy after neoadjuvant chemotherapy for locally advanced cervical cancer
    Cai, Jing
    Yang, Lu
    Dong, Weihong
    Wang, Hongbo
    Xiong, Zhoufang
    Wang, Zehua
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2016, 132 (01) : 29 - 33
  • [47] Feasibility of robotic radical hysterectomy after neoadjuvant chemotherapy in women with locally advanced cervical cancer
    Minig, L.
    Zanagnolo, V.
    Cardenas-Rebollo, J. M.
    Colombo, N.
    Maggioni, A.
    EJSO, 2016, 42 (09): : 1372 - 1377
  • [48] Robotic Surgery in Patients With Locally Advanced Cervical Cancer After Neoadjuvant Chemotherapy Survival Outcomes
    Siesto, Gabriele
    Romano, Fabrizio
    Accardi, Antonio
    Bulletti, Cinzia
    Ieda, Nicoletta Palma
    Vitobello, Domenico
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (03) : 521 - 527
  • [49] Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer
    Sugiyama, T
    Nishida, T
    Kumagai, S
    Nishio, S
    Fujiyoshi, K
    Okura, N
    Yakushiji, M
    Hiura, M
    Umesaki, N
    BRITISH JOURNAL OF CANCER, 1999, 81 (01) : 95 - 98
  • [50] Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer
    T Sugiyama
    T Nishida
    S Kumagai
    S Nishio
    K Fujiyoshi
    N Okura
    M Yakushiji
    M Hiura
    N Umesaki
    British Journal of Cancer, 1999, 81 : 95 - 98